Search Tufts Medicine

Displaying 2001 - 2020 of 2406
clinical trial
...

The main objective of this study is to prospectively evaluate the effect of prophylactic intra-operative ventricular tachyarrhythmia ablation (VTA) at the time of left ventricular assist device (LVAD) implantation on post-implant total recurrent VTA events, after accounting for the competing risk of death, from discharge to an average follow-up of 18 months (with a minimum of 9 months) after LVAD implantation.
clinical trial
...

Patients who need vision testing (acuity and fields) will be asked to be tested at home or at the bedside with the ViuALL device. They and their phyysicians will be asked about the advantages and disadvantages of the new device. 
Announcements
August 10, 2021
Every day we have the privilege of helping people heal and become their best, healthiest selves. These individuals turn to us when they are most vulnerable and trust that we will care for them safely. To serve them well, we also must be our healthiest and best selves and the best way to be healthy amidst this ongoing pandemic is vaccination.
Announcements
July 24, 2021
Our number one priority is the health and safety of our patients, employees and clinicians. That is why today we are announcing that we will require those who work within our hospitals and health system to be vaccinated against COVID-19 following the full FDA approval of one of the current vaccines. We anticipate this happening later this year.
Press Releases
March 1, 2022
BOSTON, MA – March 1, 2022 – Wellforce, the high quality, integrated Massachusetts health system, announced today it will be uniting its member organizations under a new name – Tufts Medicine.
Press Releases
October 10, 2019
International Expert in Antimicrobial Resistance Helen W. Boucher, MD, Named Chief of the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center
Press Releases
June 2, 2020
Tufts Medical Center has named an interim Chief Scientific Officer, Dr. John Wong.
Press Releases
October 22, 2020
Tufts Medical Center announced today that it has become the first center in New England to use the drug Jelmyto (UroGen Pharma, Inc.) for treatment of upper tract urothelial cancer (UTUC), a malignancy found in the kidney lining or the ureter, the thin tube connecting the bladder to the kidneys.
Patient Stories
July 7, 2022
Eight-week-old Abegael spent six long weeks in the Pediatric Intensive Care Unit (PICU) at Tufts Medical Center in Boston battling respiratory failure due to RSV.
Patient Stories
September 20, 2019
At one month old, Michael was rushed to Tufts Medical Center's PICU for answers. Read more about "Baby Mike" and his journey at Tufts Medical Center, as he battled a scary illness while touching the lives of patients and staff with his sunny disposition.
Patient Stories
November 7, 2019
How this tough 3-year-old has impressed everyone with his strength and determination to beat cancer at Tufts Medical Center.
Patient Stories
July 7, 2022
Read the testimonial of a patient who traveled from Portugal to get exceptional care from the pediatric ENT team at Tufts Medical Center in Boston.